Mette Kirstine Agger

Insider Reports History

Entity
Individual
Location
C/O Scpharmaceuticals, Inc., 2400 District Avenue Suite 310, Burlington, MA
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mette Kirstine Agger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
scPharmaceuticals Inc. Director Stock Option (Right to Buy) 19.8K Jun 11, 2024 Direct
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 18K Jun 25, 2024 Direct

Insider Reports Filed by Mette Kirstine Agger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
SCPH scPharmaceuticals Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
LXEO Lexeo Therapeutics, Inc. Feb 2, 2024 1 $0 4 Feb 6, 2024 Director
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 Director
SCPH scPharmaceuticals Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director